Show Summary Details
Page of

Patients with Substance Use Disorder 

Patients with Substance Use Disorder
Chapter:
Patients with Substance Use Disorder
Author(s):

Jeannine M. Brant

DOI:
10.1093/med/9780190204747.003.0054
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 October 2019

Substance use disorders (SUD) are a growing concern across the United States. This chapter uses a case study to address palliative care assessment and management of patients with addiction and substance use disorders. Routine assessment for substance use disorders is essential, and several assessment tools are described. The statewide Prescription Drug Monitoring Programs are helpful in identifying patients at risk. Patient management depends on risk stratification, which is based on risk assessment tools, urine drug testing, and observation of aberrant behaviors over time. Those at highest risk for substance use undergo surveillance most frequently. Managing misuse, abuse, addiction, and diversion are primary goals of the advanced practice registered nurse caring for these patients. Open communication provides the foundation for care along with Universal Precautions, a model of care that can help stratify risk, reduce stigma, and improve overall care.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.